LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s stock price was down 19.2% on Wednesday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares changed hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Down 19.2 %
The stock has a market capitalization of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26. The firm has a 50 day simple moving average of C$0.11 and a 200-day simple moving average of C$0.11. The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Further Reading
- Five stocks we like better than LexaGene
- Consumer Discretionary Stocks Explained
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
